10,200 Shares in Merck & Co., Inc. $MRK Purchased by FNY Investment Advisers LLC

16,300 Shares in Merck & Co., Inc. $MRK Purchased by Dorato Capital Management

Eldred Rock Partners LLC Has $11.31 Million Stake in Merck & Co., Inc. $MRK

Beaumont Financial Advisors LLC Decreases Stake in Merck & Co., Inc. $MRK

Merck Announces Initiation of Pivotal Phase 2b/3 Trial Evaluating MK-8748 (Tiespectus), an Investigational Bispecific Tie2 Agonist/VEGF Inhibitor, for the Treatment of Neovascular Age-Related Macular Degeneration

European Commission Approves KEYTRUDA® (pembrolizumab) Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 (CPS ≥1) Platinum-Resistant Recurrent Ovarian Carcinoma Who Have Received One or Two Prior Systemic Treatment Regimens